Dajani N, Idriss E, Collins P L
Department of Obstetrics and Gynecology, MetroHealth Medical Center, Cleveland, Ohio 44109.
Am J Reprod Immunol. 1994 Oct;32(3):248-54. doi: 10.1111/j.1600-0897.1994.tb01120.x.
Interleukin-6 (IL-6) increases in culture-positive amniotic fluid in women with preterm labor. IL-6 stimulates the production of prostaglandins leading to increased uterine activity.
We tested the hypothesis that IL-6 increases myometrial activity through release of uterotonic mediators. We studied the effect of IL-6 on uterine contractions in the absence and presence of fetal membranes to determine if the effect was on myometrium alone or was mediated through fetal membranes/decidua. IL-6 in concentrations of 100, 10, 0.1 or 0 ng/ml was added to the maternal side of the dual chamber-fetal membrane-uterine muscle in vitro model.
We found that 10 ng/ml of IL-6 alone, without fetal membranes, caused a significant decrease in uterine contractions over time (P < or = 0.01). This decrease was not observed with the addition of term, nonlabored fetal membranes.
IL-6 in the presence or absence of membranes, over a four log fold dose range, did not stimulate uterine contractions.
早产女性羊水培养阳性时白细胞介素 - 6(IL - 6)水平升高。IL - 6刺激前列腺素生成,导致子宫活动增强。
我们检验了IL - 6通过释放宫缩剂介质增加子宫肌层活动的假说。我们研究了有无胎膜情况下IL - 6对子宫收缩的影响,以确定其作用是否仅针对子宫肌层,还是通过胎膜/蜕膜介导。将浓度为100、10、0.1或0 ng/ml的IL - 6添加到体外双腔 - 胎膜 - 子宫肌模型的母体侧。
我们发现,在无胎膜情况下,单独使用10 ng/ml的IL - 6会导致子宫收缩随时间显著减少(P≤0.01)。添加足月未临产胎膜时未观察到这种减少。
在有或无胎膜的情况下,在四个对数倍剂量范围内,IL - 6均未刺激子宫收缩。